Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2002
11/21/2002WO2002092773A2 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002WO2002092764A2 Transgenic animal model of bone mass modulation
11/21/2002WO2002092759A2 Molecules for disease detection and treatment
11/21/2002WO2002092623A1 INHIBITORS OF RECEPTOR ACTIVATOR OF NF-κB AND USES THEREOF
11/21/2002WO2002092616A1 Antisense permeation enhancers
11/21/2002WO2002092606A1 Fused imidazolidine derivatives, process for preparation of the same and use thereof
11/21/2002WO2002092594A1 Substituted 4h-chromenes and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/21/2002WO2002092593A1 4-(4-pyridazinyl)pyrazole derivatives
11/21/2002WO2002092588A2 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002WO2002092582A1 Protease-inhibitors
11/21/2002WO2002092576A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002WO2002092573A2 Heterocyclic substituted pyrazoles as inhibitors of src and other protein kinases
11/21/2002WO2002092571A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002WO2002092568A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002WO2002092567A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002WO2002092563A2 Protease inhibitors
11/21/2002WO2002092087A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002WO2002092069A1 Permeation enhancers
11/21/2002WO2002092068A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/21/2002WO2002092064A2 Therapeutic method for inducing tolerance
11/21/2002WO2002092016A2 Therapeutic use of rank antagonists
11/21/2002WO2002092015A2 Reagents and methods for modulating dkk-mediated interactions
11/21/2002WO2002092004A2 Use of hmg fragment as anti-inflammatory agents
11/21/2002WO2002092000A2 Hbm variants that modulate bone mass and lipid levels
11/21/2002WO2002091993A2 Estrogen receptor modulators
11/21/2002WO2002081728A3 Quinoline inhibitors of hyak1 and hyak3 kinases
11/21/2002WO2002078615A3 Antioxidant nitroxides and nitrones as therapeutic agents
11/21/2002WO2002074784A3 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain
11/21/2002WO2002072034A3 Chronotherapeutic dosage forms
11/21/2002WO2002055098A3 Latency associated peptide for providing latency to pharmaceutically active proteins
11/21/2002WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002WO2002012250B1 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
11/21/2002WO2001080876A8 Utilization of adamts-1 protein and method of screening aggrecanase activity regulator
11/21/2002WO2001034646A9 Recombinant gelatins
11/21/2002WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002US20020173851 Intervertebral disc treatment devices and methods
11/21/2002US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002US20020173646 Quinazoline derivatives and pharmaceutical compositions containing them
11/21/2002US20020173540 Using plant extract
11/21/2002US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002US20020173499 Estrogen replacement therapy
11/21/2002US20020173488 Boronic Ester and acid compounds, synthesis and uses
11/21/2002US20020173485 Mixture of hyaluronic acid and polyvinylpyrrolidone
11/21/2002US20020173464 Modulation of pericyte proliferation
11/21/2002US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002US20020173448 Method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
11/21/2002US20020172999 Novel KIAA1061-like cell adhesion molecule-like proteins and polynucleotides encoding them
11/21/2002DE10124041A1 New peptide-type compounds, useful as protease, especially thrombin, inhibitors for treating e.g. thrombosis and cardiac infarct
11/21/2002CA2447593A1 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
11/21/2002CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002CA2447518A1 Therapeutic use of rank antagonists
11/21/2002CA2447444A1 Antisense permeation enhancers
11/21/2002CA2447431A1 Inhibitors of receptor activator of nf-kb and uses thereof
11/21/2002CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002CA2447292A1 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002CA2446859A1 Transgenic animal model of bone mass modulation
11/21/2002CA2446821A1 Hbm variants that modulate bone mass and lipid levels
11/21/2002CA2446751A1 Kavalactone compositions and methods of use
11/21/2002CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002CA2446582A1 Reagents and methods for modulating dkk-mediated interactions
11/21/2002CA2445922A1 Estrogen receptor modulators
11/21/2002CA2445366A1 Molecules for disease detection and treatment
11/21/2002CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002EP1258471A2 Inorganic ion receptor-active compounds
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1257648A1 Antagonistic selective binding agents of osteoprotegerin binding protein
11/20/2002EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002EP1257581A1 Compounds related to or derived from gfr alpha 4 and their use
11/20/2002EP1257578A2 Transporters and ion channels
11/20/2002EP1257563A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
11/20/2002EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002EP1257552A1 Xanthine derivatives, intermediates and use for treating osteoporosis
11/20/2002EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002EP1257546A1 Kinase inhibitors
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1257543A1 Pyridinylimidazoles
11/20/2002EP1257526A1 Aniline-derived ligands for the thyroid receptor
11/20/2002EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002EP1257292A1 Use of il-18 inhibitors
11/20/2002EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002EP1257272A1 Thiazolium compounds and treatments of disorders associated with protein aging
11/20/2002EP1257264A1 Estrogen receptor modulators
11/20/2002EP1257263A2 Microcompetiton and human disease
11/20/2002EP1147101B1 Reverse hydroxamate inhibitors of matrix metalloproteinases
11/20/2002EP1112095B1 Biologically active implants
11/20/2002EP1042301B1 Novel acylguanidine derivatives as inhibitors of bone resorption and as vitronectin receptor antagonists
11/20/2002EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002EP0920422B1 Crytalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide
11/20/2002CN1380884A Novel recombinant antibodies, amino acid sequences of CDR thereof and genes encoding the same
11/20/2002CN1380288A Tetrahydroisoquinoline hydroximic acid sulfamide compound, its synthesis method and its application
11/20/2002CN1380279A (4-alkynyl), aromatic keto-acid compound, synthesis method and its application
11/20/2002CN1380095A Ointment for curing rheumatism and osteoarthropathy
1 ... 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 ... 820